CNS vs AB
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 27, 2026
CNS
67.8
AI Score
VS
CNS Wins
AB
45.9
AI Score
Investment Advisor Scores
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | CNS | AB | Winner |
|---|---|---|---|
| Net Income | 76.58M | 156.96M | AB |
| ROA | 22.0% | 12.6% | CNS |
| Total Assets | 348.45M | 1.25B | AB |
Relative Price Performance (Last 90 Days)
CNS 1M: -5.6%
· 3M: -6.9%
AB 1M: -4.5%
· 3M: -3.6%
Current Technical Phase
CNS
MarkdownSell / avoid
Price below a falling SMA50 (slope -1.8%), weak momentum, RSI 36
AB
MarkdownSell / avoid
Price below a falling SMA50 (slope -0.8%), weak momentum, RSI 38
Fundamentals Snapshot
| Metric | CNS | AB |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 18.4 | 9.3 |
| Trailing P/E | 22.4 | 10.6 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | -0.4% |
| Gross Margin | 0.5% | 1.0% |
| Operating Margin | 0.3% | 1.0% |
| EPS | 3.26 | 3.29 |
| Dividend Yield | 0.04% | 0.10% |
Frequently Asked Questions
Based on our detailed analysis, CNS is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.